Novacyt S.A (NVYTF PINK) stock market data APIs
$0.6404
0(0%)
as of March 14, 2025
Novacyt S.A Financial Data Overview
Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, France, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, and Yourgene Health segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The company was incorporated in 2006 and is based in Le Vésinet, France.
Prev. Close
0.6404
Open
0.6404
High
0.6404
Low
0.6404
52 wk Range
0.5-1.25
Market Cap
45 271 K
Shares Outstanding
70 626 K
Revenue
18 562 K
EPS
-0.1245
Beta
0.083
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Novacyt S.A data using free add-ons & libraries
Get Novacyt S.A Fundamental Data
Novacyt S.A Fundamental data includes:
- Net Revenue: 18 562 K
- EBITDA: -38 247 500
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Novacyt S.A News
New
Novacyt S.A. ("Novacyt", the "Company" or the "Group"): DHSC Claim Update – Trial Date Listed
PARIS & EASTLEIGH, England, January 30, 2023--(BUSINESS WIRE)--Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Hi...
Novacyt S.A. ("Novacyt", the "Company" or the "Group") Full Year 2022 Trading Update
Full year revenue and EBITDA in line with guidance Remain focused on post-COVID-19 growth strategy to become a leading global clinical diagnostics company in infectious diseases PARIS & EASTLEIGH, E...
Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Non-Executive Director Change
PARIS & EASTLEIGH, England, December 07, 2022--(BUSINESS WIRE)--Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that Edwin...
Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Approval of genesig® COVID-19 3G PCR Test in the UK Under CTDA Legislation
PARIS & EASTLEIGH, England, December 06, 2022--(BUSINESS WIRE)--Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the C...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
